Atezolizumab for the First-Line Treatment of Non-Small Cell Lung Cancer (NSCLC): Current Status and Future Prospects

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2018.00277
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy